| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.37B | 20.59B | 18.98B | 12.75B | 16.05B | 16.43B |
| Gross Profit | 20.22B | 20.02B | 18.19B | 12.21B | 15.62B | 16.32B |
| EBITDA | 2.54B | 5.06B | 4.65B | -1.41B | 5.24B | 1.95B |
| Net Income | 2.48B | 3.17B | 2.98B | -2.38B | 2.90B | 4.54B |
Balance Sheet | ||||||
| Total Assets | 116.78B | 109.53B | 124.12B | 98.83B | 104.72B | 107.13B |
| Cash, Cash Equivalents and Short-Term Investments | 21.05B | 25.98B | 35.51B | 24.87B | 28.09B | 18.07B |
| Total Debt | 25.30B | 19.99B | 18.90B | 12.76B | 7.95B | 5.31B |
| Total Liabilities | 70.90B | 61.93B | 65.46B | 44.81B | 46.70B | 48.78B |
| Stockholders Equity | 42.99B | 44.56B | 55.65B | 51.00B | 55.71B | 57.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.43B | 8.22B | -9.73B | -4.27B | -1.98B |
| Operating Cash Flow | 0.00 | -8.95B | 8.45B | -9.49B | -3.93B | -1.62B |
| Investing Cash Flow | 0.00 | 1.18B | 1.48B | 474.00M | 4.75B | 4.11B |
| Financing Cash Flow | 0.00 | -4.89B | -1.52B | 3.82B | 959.00M | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.96B | 6.25 | 7.66% | 5.47% | -1.80% | -1.02% | |
81 Outperform | ¥88.32B | 6.63 | ― | 5.75% | 10.85% | 30.77% | |
80 Outperform | ¥192.71B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
71 Outperform | ¥71.50B | 12.60 | 9.22% | 6.15% | 7.45% | 45.25% | |
68 Neutral | ¥52.64B | 9.12 | ― | 4.86% | 6.40% | 41.18% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥46.97B | 10.12 | ― | 4.36% | 1.14% | -16.88% |